Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schell

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Colorectal Cancer|March 29, 2021
Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal ExcisionSamer Naffouje, Arvind Sabesan, Benjamin D Powers, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancerMark A Socinski, Marcus A Neubauer, Jairo Olivares, et al.
American Journal of Clinical Oncology|June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasoneCeleste Lindley, Susan Goodin, Jeannine McCune, et al.
Nature Communications|August 27, 2016
The tumour suppressor CYLD regulates the p53 DNA damage responseVanesa Fernández-Majada, Patrick-Simon Welz, Maria A Ermolaeva, et al.
Cancer Immunology Research|February 14, 2016
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after IpilimumabJeffrey Weber, Geoffrey Gibney, Ragini Kudchadkar, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Benefits of external beam irradiation for peripheral arterial bypass: preliminary report on a phase I studyArvind B Soni, Karl A Illig, Yaron Sternbach, et al.
The Oncologist|October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung CancerAlberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Nature Communications|April 28, 2016
Exosomal microRNA miR-92a concentration in serum reflects human brown fat activityYong Chen, Joschka J Buyel, Mark J W Hanssen, et al.
Cell Reports|March 19, 2013
Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXAKerstin Brinkmann, Paola Zigrino, Axel Witt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T CellsCigdem Atay, Taekyoung Kwak, Sergio Lavilla-Alonso, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Colorectal Cancer|March 29, 2021
Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal ExcisionSamer Naffouje, Arvind Sabesan, Benjamin D Powers, et al.
Lung Cancer (Amsterdam, Netherlands)|March 28, 2003
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancerMark A Socinski, Marcus A Neubauer, Jairo Olivares, et al.
American Journal of Clinical Oncology|June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasoneCeleste Lindley, Susan Goodin, Jeannine McCune, et al.
Nature Communications|August 27, 2016
The tumour suppressor CYLD regulates the p53 DNA damage responseVanesa Fernández-Majada, Patrick-Simon Welz, Maria A Ermolaeva, et al.
Cancer Immunology Research|February 14, 2016
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after IpilimumabJeffrey Weber, Geoffrey Gibney, Ragini Kudchadkar, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Benefits of external beam irradiation for peripheral arterial bypass: preliminary report on a phase I studyArvind B Soni, Karl A Illig, Yaron Sternbach, et al.
The Oncologist|October 4, 2016
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung CancerAlberto A Chiappori, Gregory A Otterson, Afshin Dowlati, et al.
Nature Communications|April 28, 2016
Exosomal microRNA miR-92a concentration in serum reflects human brown fat activityYong Chen, Joschka J Buyel, Mark J W Hanssen, et al.
Cell Reports|March 19, 2013
Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXAKerstin Brinkmann, Paola Zigrino, Axel Witt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T CellsCigdem Atay, Taekyoung Kwak, Sergio Lavilla-Alonso, et al.
Pageof 3